• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Ulcerated, Tender Nodule on the Ear

News
Article

A painful nodule that keeps this woman up at night; treatment options for nonalcoholic fatty liver disease; risk factors for statin adverse effects . . . some of the topics in this 5-question quiz.

Question 1:

A 71-year-old woman sought medical attention for a chronically painful ear lesion.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 2:

Nonalcoholic fatty liver disease affects approximately 20% to 30% of adults in developed countries, and its prevalence has markedly increased in children and adolescents.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 3:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 4:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 5:

Headaches are a common complaint.

ANSWER KEY »


For the discussion, click here.


 

ANSWER KEY:

Question 1. C

Question 2. G

Question 3. A

Question 4. C

Question 5. G

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Aggressive Risk Factor Management Reduced Recurrent AF by Nearly Half After Catheter Ablation / image courtesy of Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital

Aggressive Risk Factor Management Reduced Recurrent AF by Nearly Half After Catheter Ablation

Grace Halsey
October 31st 2025
Article

The rate of AF recurrence was reduced significantly and participants also experienced improvements in self-reported AF severity as well as improved cardiometabolic measures.

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Sydney Jennings
September 24th 2025
Podcast

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Model Predicts Complications of T2D and Progression Based on Risk Factors

Mathematical Model Forecasts Diabetes Complications 15 Years Out, Confirms Legacy Effect of Early Control

Grace Halsey
October 30th 2025
Article

The model predicts 14 different T2D complications that can develop over ~15 years, and models how the disease progresses by predicting change in risk factors over time.

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
August 28th 2025
Podcast

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

AI-Powered Diabetes Prevention Program Intervention Matches Human Coaching in Landmark Trial

AI-Powered Diabetes Prevention Program Intervention Matches Human Coaching in Landmark Trial

Grace Halsey
October 27th 2025
Article

After 1 year of coaching by the AI app or a DPP-associated coach, reductions in weight and HbA1c and increases in physical activity were equal, an outcome with great promise for scalability.

Semaglutide Cardioprotective Effects Appear Independent of Baseline Adiposity, Suggesting Disease-Modifying Potential / image credit John Deanfield, CBE Courtesy of University College London

Semaglutide CV Effects Appear Independent of Baseline Adiposity, Suggesting Disease-Modifying Potential

Grace Halsey
October 23rd 2025
Article

In a subanalysis of the SELECT trial, semaglutide was associated with reduction in MACE across weight and waist circumference categories, independent of body fat.

© 2025 MJH Life Sciences

All rights reserved.